147 related articles for article (PubMed ID: 1607344)
1. Apoptotic megakaryocyte dysplasia in the myelodysplastic syndromes.
Hatfill SJ; Fester ED; Steytler JG
Hematol Pathol; 1992; 6(2):87-93. PubMed ID: 1607344
[TBL] [Abstract][Full Text] [Related]
2. [LAT (linker for activation of T cells): a useful marker for megakaryocyte evaluation on bone marrow biopsies].
Ungari M; Pellegrini W; Borlenghi E; Marocolo D; Ubiali A; Agazzi C; Pich A; Franco V; Facchetti F
Pathologica; 2002 Dec; 94(6):325-30. PubMed ID: 12540999
[TBL] [Abstract][Full Text] [Related]
3. AIDS-related bone marrow lesions--myelodysplastic features or predominant inflammatory-reactive changes (HIV-myelopathy)? A comparative morphometric study by immunohistochemistry with special emphasis on apoptosis and PCNA-labeling.
Thiele J; Zirbes TK; Bertsch HP; Titius BR; Lorenzen J; Fischer R
Anal Cell Pathol; 1996 Aug; 11(3):141-57. PubMed ID: 8888951
[TBL] [Abstract][Full Text] [Related]
4. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
5. A megakaryocyte analysis of the bone marrow in patients with myelodysplastic syndrome, myeloproliferative disorder and allied disorders.
Ohshima K; Kikuchi M; Takeshita M
J Pathol; 1995 Oct; 177(2):181-9. PubMed ID: 7490685
[TBL] [Abstract][Full Text] [Related]
6. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
7. [Importance of immunomorphometric evaluation of the size and number of megakaryocytes in normal and pathologic bone marrow].
Marisavljević D; Rolović Z; Mitrović D
Srp Arh Celok Lek; 1993; 121(3-7):57-61. PubMed ID: 7716637
[TBL] [Abstract][Full Text] [Related]
8. von Willebrand factor is the most reliable immunohistochemical marker for megakaryocytes of myelodysplastic syndrome and chronic myeloproliferative disorders.
Chuang SS; Jung YC; Li CY
Am J Clin Pathol; 2000 Apr; 113(4):506-11. PubMed ID: 10761451
[TBL] [Abstract][Full Text] [Related]
9. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes.
Maratheftis CI; Bolaraki PE; Voulgarelis M
Am J Hematol; 2007 Oct; 82(10):887-92. PubMed ID: 17570514
[TBL] [Abstract][Full Text] [Related]
10. Angiogenesis in myelodysplastic syndromes.
Pruneri G; Bertolini F; Soligo D; Carboni N; Cortelezzi A; Ferrucci PF; Buffa R; Lambertenghi-Deliliers G; Pezzella F
Br J Cancer; 1999 Dec; 81(8):1398-401. PubMed ID: 10604739
[TBL] [Abstract][Full Text] [Related]
11. High-level CD34 expression on megakaryocytes independently predicts an adverse outcome in patients with myelodysplastic syndromes.
Tang G; Wang SA; Menon M; Dresser K; Woda BA; Hao S
Leuk Res; 2011 Jun; 35(6):766-70. PubMed ID: 21367453
[TBL] [Abstract][Full Text] [Related]
12. Assessment of stromal function, and its potential contribution to deregulation of hematopoiesis in the myelodysplastic syndromes.
Tauro S; Hepburn MD; Bowen DT; Pippard MJ
Haematologica; 2001 Oct; 86(10):1038-45. PubMed ID: 11602409
[TBL] [Abstract][Full Text] [Related]
13. Naked megakaryocyte nuclei in bone marrows of patients with acquired immunodeficiency syndrome: a somewhat specific finding.
Gordon S; Lee S
Mod Pathol; 1994 Feb; 7(2):166-8. PubMed ID: 8008737
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical study of Ulex europaeus agglutinin 1 (UEA-1) binding of megakaryocytes in bone marrow biopsy specimens: demonstration of heterogeneity in staining pattern reflecting the stages of differentiation.
Liu SM; Li CY
Hematopathol Mol Hematol; 1996; 10(1-2):99-109. PubMed ID: 8792151
[TBL] [Abstract][Full Text] [Related]
15. Studies of the bone marrow in polycythemia vera and the evolution of myelofibrosis and second hematologic malignancies.
Ellis JT; Peterson P; Geller SA; Rappaport H
Semin Hematol; 1986 Apr; 23(2):144-55. PubMed ID: 3704666
[TBL] [Abstract][Full Text] [Related]
16. Megakaryopoiesis and myelofibrosis in chronic myeloid leukemia after allogeneic bone marrow transplantation: an immunohistochemical study of 127 patients.
Thiele J; Kvasnicka HM; Beelen DW; Flucke U; Spoer C; Paperno S; Leder LD; Schaefer UW
Mod Pathol; 2001 Feb; 14(2):129-38. PubMed ID: 11235904
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous intramedullary apoptosis is present in disorders other than myelodysplasia.
Irvine AE; Magill MK; Somerville LE; McMullin MF
Exp Hematol; 1998 May; 26(5):435-9. PubMed ID: 9590661
[TBL] [Abstract][Full Text] [Related]
18. [Study on apoptosis in myelodysplastic syndromes by DNA in situ end labelling combined with APAAP].
Li X; Pu Q; Liu Y; Shi J; Tao Y; Chang C; Jiang Q; Huang W
Zhonghua Xue Ye Xue Za Zhi; 2002 Jan; 23(1):27-9. PubMed ID: 12015085
[TBL] [Abstract][Full Text] [Related]
19. [Histopathologic diagnosis of bone marrow in leukemia and related disorders].
Kikuchi M; Ohshima K; Kobari S
Rinsho Byori; 1991 Dec; 39(12):1245-9. PubMed ID: 1779461
[TBL] [Abstract][Full Text] [Related]
20. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
Stifter G; Heiss S; Gastl G; Tzankov A; Stauder R
Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
